PTGES2 antibody (AA 106-313)
Quick Overview for PTGES2 antibody (AA 106-313) (ABIN467562)
Target
See all PTGES2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 106-313
-
Specificity
- Human PTGES2. Predicted cross-reactivity based on amino acid sequence homology: mouse (89 % ), rat (88 %), bovine (87 %), dogs (92 %).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Recombinant protein fragment containing a sequence corresponding to a region within amino acids 106 and 313 of Human PTGES2.
Type of Immunogen: Recombinant protein
-
-
-
-
Application Notes
- Approved: IHC, IHC-P (10 μg/mL), WB (1:500 - 1:3000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7, 10 % Glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C. Avoid freeze-thaw cycles.
-
-
- PTGES2 (Prostaglandin E Synthase 2 (PTGES2))
-
Alternative Name
- PTGES2
-
Background
-
Name/Gene ID: PTGES2
Synonyms: PTGES2, C9orf15, GATE-binding factor 1, GBF-1, MPGES-2, PGES2, Prostaglandin E synthase 2 -
Gene ID
- 80142
-
UniProt
- Q9H7Z7
-
Pathways
- Interferon-gamma Pathway, Cell RedoxHomeostasis, SARS-CoV-2 Protein Interactome
Target
-